Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Immediate-Response Detection System for γ-Hydroxybutyrate to Enhance Personal Safety in Social Environments.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Temporal immunomodulation of CD4<sup>+</sup> T cells by magnesium regulates osteoimmune responses in osteoporotic fracture healing.

Science advances·2026
Same author

Miniaturized subcutaneous cellular implants for sustained therapeutic protein delivery in resource-limited settings.

bioRxiv : the preprint server for biology·2026
Same author

Mitochondrial Transfer to Endothelial Cells: Mechanisms, Evidence, and Therapeutic Potential.

Circulation research·2026
Same author

Dual-sprayable, multi-functional hydrogel for effective prevention of peritoneal adhesions.

Journal of tissue engineering·2026
Same author

Borrowed mitochondria, spared neurons.

Cell research·2026

Related Experiment Video

Updated: May 9, 2025

Fabricating a Kidney Cortex Extracellular Matrix-Derived Hydrogel
08:23

Fabricating a Kidney Cortex Extracellular Matrix-Derived Hydrogel

Published on: October 13, 2018

10.3K

Development of a Decellularized Urinary Bladder Matrix and Heparin-Based Cryogel for Promoting Angiogenesis.

Dayeon Roo1, Minkyu Lee2, Sivashanmugam Amirthalingam3

  • 1Interdisciplinary Program in Bioengineering, Seoul National University, Seoul, 08826, Republic of Korea.

Macromolecular Bioscience
|April 30, 2025
PubMed
Summary

This study introduces decellularized extracellular matrix (dECM) cryogel scaffolds for sustained vascular endothelial growth factor (VEGF) release, enhancing blood vessel formation in ischemic tissues. The dECM/heparin cryogels show promise for tissue regeneration and therapeutic angiogenesis.

Keywords:
cryogeldecellularizationneovascularizationurinary bladder matrixvascular endothelial growth factor

More Related Videos

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs
04:05

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs

Published on: July 5, 2024

214
Tissue Engineering of a Human 3D in vitro Tumor Test System
11:12

Tissue Engineering of a Human 3D in vitro Tumor Test System

Published on: August 6, 2013

21.2K

Related Experiment Videos

Last Updated: May 9, 2025

Fabricating a Kidney Cortex Extracellular Matrix-Derived Hydrogel
08:23

Fabricating a Kidney Cortex Extracellular Matrix-Derived Hydrogel

Published on: October 13, 2018

10.3K
Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs
04:05

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs

Published on: July 5, 2024

214
Tissue Engineering of a Human 3D in vitro Tumor Test System
11:12

Tissue Engineering of a Human 3D in vitro Tumor Test System

Published on: August 6, 2013

21.2K

Area of Science:

  • Biomaterials Science
  • Tissue Engineering
  • Regenerative Medicine

Background:

  • Decellularized extracellular matrix (dECM)-based scaffolds support cellular migration and tissue regeneration.
  • Sustained delivery of vascular endothelial growth factor (VEGF) is crucial for therapeutic angiogenesis but challenging.
  • Cryogels offer a promising platform for controlled drug delivery due to their unique properties.

Purpose of the Study:

  • To develop dECM-based cryogel scaffolds for sustained VEGF release.
  • To enhance angiogenesis in ischemic tissues using these novel scaffolds.
  • To evaluate the angiogenic potential of VEGF-releasing dECM/heparin cryogels in vitro and in vivo.

Main Methods:

  • Fabrication of dECM/heparin cryogel scaffolds using decellularized porcine urinary bladder matrix.
  • Incorporation of VEGF into the cryogel matrix for sustained release.
  • In vitro and in vivo evaluation of scaffold biocompatibility and angiogenic efficacy in a murine hindlimb ischemia model.

Main Results:

  • The fabricated dECM/heparin cryogel scaffolds demonstrated biocompatibility.
  • The scaffolds effectively bound and released VEGF over an extended period.
  • Significant angiogenic potential was observed both in vitro and in the in vivo ischemia model.

Conclusions:

  • dECM-based cryogel scaffolds provide a viable platform for sustained VEGF delivery.
  • This technology shows significant promise for promoting angiogenesis and tissue regeneration in ischemic conditions.
  • The dECM/heparin cryogel platform holds potential for therapeutic applications in regenerative medicine.